Voloridge Investment Management
PTCT icon

Voloridge Investment Management’s PTC Therapeutics PTCT Stock Holding History

Voloridge Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-159,596
Closed -$9.79M – 1322
2025
Q3 		$9.79M Sell
159,596
-84,005
-34% -$4.38M 0.03% 545
2025
Q2 		$11.9M Sell
243,601
-216,827
-47% -$10.3M 0.04% 493
2025
Q1 		$23.5M Sell
460,428
-107,936
-19% -$5.39M 0.09% 311
2024
Q4 		$25.7M Sell
568,364
-92,168
-14% -$3.94M 0.09% 283
2024
Q3 		$24.5M Sell
660,532
-122,530
-16% -$4.1M 0.09% 322
2024
Q2 		$23.9M Buy
783,062
+23,681
+3% +$767K 0.09% 311
2024
Q1 		$22.1M Sell
759,381
-60,365
-7% -$1.69M 0.08% 304
2023
Q4 		$22.6M Buy
819,746
+646,513
+373% +$14.8M 0.09% 292
2023
Q3 		$3.88M Buy
+173,233
New +$6.44M 0.02% 728
2022
Q4 		– Sell
-102,299
Closed -$5.13M – 1600
2022
Q3 		$5.13M Buy
+102,299
New +$5.01M 0.03% 645
2022
Q1 		– Sell
-19,226
Closed -$766K – 1647
2021
Q4 		$766K Buy
+19,226
New +$736K ﹤0.01% 1331
2021
Q3 		– Sell
-23,040
Closed -$974K – 1824
2021
Q2 		$974K Sell
23,040
-31,051
-57% -$1.33M 0.01% 1261
2021
Q1 		$2.56M Buy
+54,091
New +$3.21M 0.02% 735
2020
Q2 		– Sell
-30,186
Closed -$1.35M – 1450
2020
Q1 		$1.35M Sell
30,186
-76,883
-72% -$3.87M 0.04% 437
2019
Q4 		$5.14M Buy
+107,069
New +$4.55M 0.1% 255
2019
Q1 		– Sell
-12,461
Closed -$428K – 1035
2018
Q4 		$428K Buy
+12,461
New +$448K 0.02% 345
2015
Q4 		– Sell
-24,503
Closed -$654K – 282
2015
Q3 		$654K Buy
+24,503
New +$1.05M 0.03% 241
2015
Q2 		– Sell
-121,315
Closed -$7.38M – 372
2015
Q1 		$7.38M Buy
+121,315
New +$7.4M 0.36% 85

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Voloridge Investment Management's PTCT Position: Q4 2025 in Review

Voloridge Investment Management sold out of PTC Therapeutics (PTCT) in Q4 2025, closing a stake of 159,596 shares — an estimated $9.79M sold.

Voloridge Investment Management first reported a position in PTCT in Q1 2015 and held it in 18 quarters. The position peaked at $25.7M in Q4 2024. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • Voloridge Investment Management reported no remaining PTC Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 159,596 PTC Therapeutics shares in Q4 2025, an estimated $9.79M.
  • Voloridge Investment Management first reported a position in PTC Therapeutics in Q1 2015 and held it in 18 quarters.
  • Voloridge Investment Management's PTC Therapeutics position peaked at $25.7M in Q4 2024.
  • 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.